Advertisement

Treatment and Physiology in Parkinson’s Disease and Dystonia: Using Transcranial Magnetic Stimulation to Uncover the Mechanisms of Action

  • Aparna Wagle Shukla
  • David E. Vaillancourt
Movement Disorders (M Okun, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Movement Disorders

Abstract

Transcranial magnetic stimulation (TMS) has served as an important technological breakthrough in the field of the physiology of movement disorders over the last three decades. TMS has grown popular owing to the ease of application as well as its painless and noninvasive character. The technique has provide important insights into understanding the pathophysiology of movement disorders, particularly Parkinson’s disease and dystonia. The basic applications have included the study of motor cortex excitability, functioning of excitatory and inhibitory circuits, study of interactions between sensory and motor systems, and the plasticity response of the brain. TMS has also made important contributions to understanding the response to treatments such as dopaminergic medications, botulinum toxin injections, and deep brain stimulation surgery. This review summarizes the knowledge gained to date with TMS in Parkinson’s disease and dystonia, and highlights the current challenges in the use of TMS technology.

Keywords

Transcranial magnetic stimulation Parkinson’s disease Dystonia 

Notes

Acknowledgments

This work was supported by the University of Florida, Clinical and Translation Science Institute sponsored NIH KL2 TR000065 (Aparna Wagle Shukla), NIH R01 NS052318 (David E. Vaillancourt), and R01 NS075012 (David E. Vaillancourt), the Bachmann-Straus Dystonia & Parkinson Foundation (David E. Vaillancourt) and Tyler’s Hope Foundation (David E. Vaillancourt).

Compliance with Ethics Guidelines

Conflict of Interest

AparnaWagle Shukla has pending (not pending) but received grants from the Clinical and Translation Science Institute CTSI (KL2) and the Dystonia Coalition, Dystonia Medical Research Foundation.

David E. Vaillancourt has received an NIH grant (R01 NS52318, R01 NS58487) and a grant from the Bachmann-Strauss Dystonia & Parkinson Foundation and Tyler’s Hope Foundation. He has also received board membership payments as an NIH study section member and consultancy fees from the University of Texas Southwestern Medical School and the University of Illinois at Chicago. He has also received honoraria from the University of Colorado and the University of Pittsburgh.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Hallett M. Transcranial magnetic stimulation: a primer. Neuron. 2007;55(2):187–99.PubMedGoogle Scholar
  2. 2.
    Merton PA, Morton HB. Stimulation of the cerebral cortex in the intact human subject. Nature. 1980;285(5762):227.PubMedGoogle Scholar
  3. 3.
    Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1(8437):1106–7.PubMedGoogle Scholar
  4. 4.
    Amassian VE, Cracco RQ, Maccabee PJ, Cracco JB, Rudell A, Eberle L. Suppression of visual perception by magnetic coil stimulation of human occipital cortex. Electroencephalogr Clin Neurophysiol. 1989;74(6):458–62.PubMedGoogle Scholar
  5. 5.
    Cantello R. Applications of transcranial magnetic stimulation in movement disorders. J Clin Neurophysiol. 2002;19(4):272–93.PubMedGoogle Scholar
  6. 6.
    Chen R. Interactions between inhibitory and excitatory circuits in the human motor cortex. Exp Brain Res. 2004;154(1):1–10.PubMedGoogle Scholar
  7. 7.
    Rothwell JC. Techniques and mechanisms of action of transcranial stimulation of the human motor cortex. J Neurosci Methods. 1997;74(2):113–22.PubMedGoogle Scholar
  8. 8.
    Pascual-Leone A, Tormos JM, Keenan J, Tarazona F, Canete C, Catala MD. Study and modulation of human cortical excitability with transcranial magnetic stimulation. J Clin Neurophysiol. 1998;15(4):333–43.PubMedGoogle Scholar
  9. 9.
    Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, et al. Corticocortical inhibition in human motor cortex. J Physiol. 1993;471:501–19.PubMedCentralPubMedGoogle Scholar
  10. 10.
    Sanger TD, Garg RR, Chen R. Interactions between two different inhibitory systems in the human motor cortex. J Physiol. 2001;530(2):307–17.PubMedCentralPubMedGoogle Scholar
  11. 11.
    Roshan L, Paradiso GO, Chen R. Two phases of short-interval intracortical inhibition. Exp Brain Res. 2003;151(3):330–7.PubMedGoogle Scholar
  12. 12.
    Chen R, Yung D, Li JY. Organization of ipsilateral excitatory and inhibitory pathways in the human motor cortex. J Neurophysiol. 2003;89(3):1256–64.PubMedGoogle Scholar
  13. 13.
    Valls-Sole J, Pascual-Leone A, Brasil-Neto JP, Cammarota A, McShane L, Hallett M. Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson’s disease. Neurology. 1994;44(4):735–41.PubMedGoogle Scholar
  14. 14.
    Wassermann EM, Samii A, Mercuri B, Ikoma K, Oddo D, Grill SE, et al. Responses to paired transcranial magnetic stimuli in resting, active, and recently activated muscles. Exp Brain Res. 1996;109(1):158–63.PubMedGoogle Scholar
  15. 15.
    Priori A, Berardelli A, Inghilleri M, Accornero N, Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson’s disease and drug-induced parkinsonism. Brain. 1994;117(2):317–23.PubMedGoogle Scholar
  16. 16.
    Chen R, Wassermann EM, Canos M, Hallett M. Impaired inhibition in writer’s cramp during voluntary muscle activation. Neurology. 1997;49(4):1054–9.PubMedGoogle Scholar
  17. 17.
    Ziemann U, Rothwell JC, Ridding MC. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol. 1996;496(3):873–81.PubMedCentralPubMedGoogle Scholar
  18. 18.
    Strafella AP, Paus T. Cerebral blood-flow changes induced by paired-pulse transcranial magnetic stimulation of the primary motor cortex. J Neurophysiol. 2001;85(6):2624–9.PubMedGoogle Scholar
  19. 19.
    Chen R, Corwell B, Hallett M. Modulation of motor cortex excitability by median nerve and digit stimulation. Exp Brain Res. 1999;129(1):77–86.PubMedGoogle Scholar
  20. 20.
    Forss N, Hari R, Salmelin R, Ahonen A, Hamalainen M, Kajola M, et al. Activation of the human posterior parietal cortex by median nerve stimulation. Exp Brain Res. 1994;99(2):309–15.PubMedGoogle Scholar
  21. 21.
    Allison T, McCarthy G, Wood CC, Darcey TM, Spencer DD, Williamson PD. Human cortical potentials evoked by stimulation of the median nerve. I. Cytoarchitectonic areas generating short-latency activity. J Neurophysiol. 1989;62(3):694–710.PubMedGoogle Scholar
  22. 22.
    Classen J, Steinfelder B, Liepert J, Stefan K, Celnik P, Cohen LG, et al. Cutaneomotor integration in humans is somatotopically organized at various levels of the nervous system and is task dependent. Exp Brain Res. 2000;130(1):48–59.PubMedGoogle Scholar
  23. 23.
    Richardson SP, Bliem B, Lomarev M, Shamim E, Dang N, Hallett M. Changes in short afferent inhibition during phasic movement in focal dystonia. Muscle Nerve. 2008;37(3):358–63.PubMedGoogle Scholar
  24. 24.
    Ugawa Y, Uesaka Y, Terao Y, Hanajima R, Kanazawa I. Magnetic stimulation over the cerebellum in humans. Ann Neurol. 1995;37(6):703–13.PubMedGoogle Scholar
  25. 25.
    Werhahn KJ, Taylor J, Ridding M, Meyer BU, Rothwell JC. Effect of transcranial magnetic stimulation over the cerebellum on the excitability of human motor cortex. Electroencephalogr Clin Neurophysiol. 1996;101(1):58–66.PubMedGoogle Scholar
  26. 26.
    Ugawa Y, Day BL, Rothwell JC, Thompson PD, Merton PA, Marsden CD. Modulation of motor cortical excitability by electrical stimulation over the cerebellum in man. J Physiol. 1991;441:57–72.PubMedCentralPubMedGoogle Scholar
  27. 27.
    Pinto AD, Chen R. Suppression of the motor cortex by magnetic stimulation of the cerebellum. Exp Brain Res. 2001;140(4):505–10.PubMedGoogle Scholar
  28. 28.
    Pinto AD, Lang AE, Chen R. The cerebellothalamocortical pathway in essential tremor. Neurology. 2003;60(12):1985–7.PubMedGoogle Scholar
  29. 29.
    Ni Z, Pinto AD, Lang AE, Chen R. Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol. 2010;68(6):816–24.PubMedGoogle Scholar
  30. 30.
    Butler AJ, Wolf SL. Putting the brain on the map: use of transcranial magnetic stimulation to assess and induce cortical plasticity of upper-extremity movement. Phys Ther. 2007;87(6):719–36.PubMedGoogle Scholar
  31. 31.
    Feldman DE. The spike-timing dependence of plasticity. Neuron. 2012;75(4):556–71.PubMedCentralPubMedGoogle Scholar
  32. 32.
    Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. 2004;44(1):5–21.PubMedGoogle Scholar
  33. 33.
    Player MJ, Taylor JL, Alonzo A, Loo CK. Paired associative stimulation increases motor cortex excitability more effectively than theta-burst stimulation. Clin Neurophysiol. 2012;123(11):2220–6.PubMedGoogle Scholar
  34. 34.
    Wu AD, Fregni F, Simon DK, Deblieck C, Pascual-Leone A. Noninvasive brain stimulation for Parkinson’s disease and dystonia. Neurotherapeutics. 2008;5(2):345–61.PubMedCentralPubMedGoogle Scholar
  35. 35.
    Zangen A, Roth Y, Voller B, Hallett M. Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol. 2005;116(4):775–9.PubMedGoogle Scholar
  36. 36.
    Epstein CM, Davey KR. Iron-core coils for transcranial magnetic stimulation. J Clin Neurophysiol. 2002;19(4):376–81.PubMedGoogle Scholar
  37. 37.
    Jahanshahi M, Brown RG, Marsden CD. A comparative study of simple and choice reaction time in Parkinson’s, Huntington’s and cerebellar disease. J Neurol Neurosurg Psychiatry. 1993;56(11):1169–77.PubMedCentralPubMedGoogle Scholar
  38. 38.
    Phillips JG, Martin KE, Bradshaw JL, Iansek R. Could bradykinesia in Parkinson’s disease simply be compensation? J Neurol. 1994;241(7):439–47.PubMedGoogle Scholar
  39. 39.
    Cunnington R, Iansek R, Thickbroom GW, Laing BA, Mastaglia FL, Bradshaw JL, et al. Effects of magnetic stimulation over supplementary motor area on movement in Parkinson’s disease. Brain. 1996;119(3):815–22.PubMedGoogle Scholar
  40. 40.
    Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson’s disease. Ann Neurol. 1995;37(2):181–8.PubMedGoogle Scholar
  41. 41.
    Filippi MM, Oliveri M, Pasqualetti P, Cicinelli P, Traversa R, Vernieri F, et al. Effects of motor imagery on motor cortical output topography in Parkinson’s disease. Neurology. 2001;57(1):55–61.PubMedGoogle Scholar
  42. 42.
    Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory symptoms in parkinsonism. Neurology. 1976;26(5):423–9.PubMedGoogle Scholar
  43. 43.
    Jobst EE, Melnick ME, Byl NN, Dowling GA, Aminoff MJ. Sensory perception in Parkinson disease. Arch Neurol. 1997;54(4):450–4.PubMedGoogle Scholar
  44. 44.
    Maschke M, Gomez CM, Tuite PJ, Konczak J. Dysfunction of the basal ganglia, but not the cerebellum, impairs kinaesthesia. Brain. 2003;126(10):2312–22.PubMedGoogle Scholar
  45. 45.
    Sailer A, Molnar GF, Paradiso G, Gunraj CA, Lang AE, Chen R. Short and long latency afferent inhibition in Parkinson’s disease. Brain. 2003;126(8):1883–94.PubMedGoogle Scholar
  46. 46.•
    Kishore A, Popa T, Velayudhan B, Joseph T, Balachandran A, Meunier S. Acute dopamine boost has a negative effect on plasticity of the primary motor cortex in advanced Parkinson’s disease. Brain. 2012;135(7):2074–88. Kishore et al. used a TMS-based plasticity protocol in their study of PD patients. They found levodopa challenge worsens LTD-like plasticity and worsens LTP-like plasticity in nondyskinetic motor fluctuators.PubMedGoogle Scholar
  47. 47.
    Cunic D, Roshan L, Khan FI, Lozano AM, Lang AE, Chen R. Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson’s disease. Neurology. 2002;58(11):1665–72.PubMedGoogle Scholar
  48. 48.
    Dauper J, Peschel T, Schrader C, Kohlmetz C, Joppich G, Nager W, et al. Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability. Neurology. 2002;59(5):700–6.PubMedGoogle Scholar
  49. 49.
    Sailer A, Cunic DI, Paradiso GO, Gunraj CA, Wagle-Shukla A, Moro E, et al. Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease. Neurology. 2007;68(5):356–63.PubMedGoogle Scholar
  50. 50.•
    Wagle Shukla A, Moro E, Gunraj C, Lozano A, Hodaie M, Lang A, et al. Long-term subthalamic nucleus stimulation improves sensorimotor integration and proprioception. J Neurol Neurosurg Psychiatry. 2013;84(9):1020–8. Wagle Shukla et al. conducted a longitudinal study in PD patients and found that chronic STN DBS is required to correct the abnormal sensorimotor integration.PubMedGoogle Scholar
  51. 51.•
    Kojovic M, Caronni A, Bologna M, Rothwell JC, Bhatia KP, Edwards MJ. Botulinum toxin injections reduce associative plasticity in patients with primary dystonia. Mov Disord. 2011;26(7):1282–9. Kojovic et al. found SICI is corrected and the PAS effect is reduced at the peak dose effects of botulinum toxin injections in patients with dystonia.PubMedCentralPubMedGoogle Scholar
  52. 52.•
    Ruge D, Tisch S, Hariz MI, Zrinzo L, Bhatia KP, Quinn NP, et al. Deep brain stimulation effects in dystonia: time course of electrophysiological changes in early treatment. Mov Disord. 2011;26(10):1913–21. Ruge et al. examined dystonia patients who underwent bilateral GPi DBS surgery. They used TMS to find abnormalities in the inhibitory circuit (SICI) are corrected at 1 month; however, at 6 months after GPi DBS surgery, the plasticity response, which is abnormally enhanced in dystonia, becomes reduced.PubMedCentralPubMedGoogle Scholar
  53. 53.
    Buhmann C, Gorsler A, Baumer T, Hidding U, Demiralay C, Hinkelmann K, et al. Abnormal excitability of premotor-motor connections in de novo Parkinson’s disease. Brain. 2004;127(12):2732–46.PubMedGoogle Scholar
  54. 54.
    Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord. 2001;16(3):448–58.PubMedGoogle Scholar
  55. 55.
    Cotzias GC, Papavasiliou PS, Gellene R. Modification of Parkinsonism—chronic treatment with L-dopa. N Engl J Med. 1969;280(7):337–45.PubMedGoogle Scholar
  56. 56.
    Chase TN. Striatal plasticity and extrapyramidal motor dysfunction. Parkinsonism Relat Disord. 2004;10(5):305–13.PubMedGoogle Scholar
  57. 57.
    Wagle Shukla A, Okun MS. Surgical treatment of Parkinson’s disease: patients, targets, devices, and approaches. Neurotherapeutics. 2014;11(1):47–59.PubMedGoogle Scholar
  58. 58.
    Hutchison WD, Allan RJ, Opitz H, Levy R, Dostrovsky JO, Lang AE, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson’s disease. Ann Neurol. 1998;44(4):622–8.PubMedGoogle Scholar
  59. 59.
    Hamani C, Saint-Cyr JA, Fraser J, Kaplitt M, Lozano AM. The subthalamic nucleus in the context of movement disorders. Brain. 2004;127(1):4–20.PubMedGoogle Scholar
  60. 60.
    Vitek JL. Mechanisms of deep brain stimulation: excitation or inhibition. Mov Disord. 2002;17 Suppl 3:S69–72.PubMedGoogle Scholar
  61. 61.
    Hamani C, Richter E, Schwalb JM, Lozano AM. Bilateral subthalamic nucleus stimulation for Parkinson’s disease: a systematic review of the clinical literature. Neurosurgery. 2005;56(6):1313–21. discussion 1321–4.PubMedGoogle Scholar
  62. 62.
    Ashby P, Paradiso G, Saint-Cyr JA, Chen R, Lang AE, Lozano AM. Potentials recorded at the scalp by stimulation near the human subthalamic nucleus. Clin Neurophysiol. 2001;112(3):431–7.PubMedGoogle Scholar
  63. 63.
    MacKinnon CD, Webb RM, Silberstein P, Tisch S, Asselman P, Limousin P, et al. Stimulation through electrodes implanted near the subthalamic nucleus activates projections to motor areas of cerebral cortex in patients with Parkinson’s disease. Eur J Neurosci. 2005;21(5):1394–402.PubMedGoogle Scholar
  64. 64.
    Kuriakose R, Saha U, Castillo G, Udupa K, Ni Z, Gunraj C, et al. The nature and time course of cortical activation following subthalamic stimulation in Parkinson’s disease. Cereb Cortex. 2010;20(8):1926–36.PubMedGoogle Scholar
  65. 65.
    Strafella AP, Vanderwerf Y, Sadikot AF. Transcranial magnetic stimulation of the human motor cortex influences the neuronal activity of subthalamic nucleus. Eur J Neurosci. 2004;20(8):2245–9.PubMedGoogle Scholar
  66. 66.
    Gaynor LM, Kuhn AA, Dileone M, Litvak V, Eusebio A, Pogosyan A, et al. Suppression of beta oscillations in the subthalamic nucleus following cortical stimulation in humans. Eur J Neurosci. 2008;28(8):1686–95.PubMedGoogle Scholar
  67. 67.
    Chen R, Garg RR, Lozano AM, Lang AE. Effects of internal globus pallidus stimulation on motor cortex excitability. Neurology. 2001;56(6):716–23.PubMedGoogle Scholar
  68. 68.
    Bressman SB. Dystonia. Curr Opin Neurol. 1998;11(4):363–72.PubMedGoogle Scholar
  69. 69.
    Fahn S, Bressman SB, Marsden CD. Classification of dystonia. Adv Neurol. 1998;78:1–10.PubMedGoogle Scholar
  70. 70.
    Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD. The pathophysiology of primary dystonia. Brain. 1998;121(7):1195–212.PubMedGoogle Scholar
  71. 71.
    Chen R, Hallett M. Focal dystonia and repetitive motion disorders. Clin Orthop Relat Res. 1998;351:102–6.PubMedGoogle Scholar
  72. 72.
    Espay AJ, Morgante F, Purzner J, Gunraj CA, Lang AE, Chen R. Cortical and spinal abnormalities in psychogenic dystonia. Ann Neurol. 2006;59(5):825–34.PubMedGoogle Scholar
  73. 73.
    Quartarone A, Rizzo V, Terranova C, Morgante F, Schneider S, Ibrahim N, et al. Abnormal sensorimotor plasticity in organic but not in psychogenic dystonia. Brain. 2009;132(10):2871–7.PubMedCentralPubMedGoogle Scholar
  74. 74.
    Abbruzzese G, Marchese R, Buccolieri A, Gasparetto B, Trompetto C. Abnormalities of sensorimotor integration in focal dystonia: a transcranial magnetic stimulation study. Brain. 2001;124(3):537–45.PubMedGoogle Scholar
  75. 75.
    Martino D, Defazio G, Alessio G, Abbruzzese G, Girlanda P, Tinazzi M, et al. Relationship between eye symptoms and blepharospasm: a multicenter case–control study. Mov Disord. 2005;20(12):1564–70.PubMedGoogle Scholar
  76. 76.
    Bara-Jimenez W, Shelton P, Hallett M. Spatial discrimination is abnormal in focal hand dystonia. Neurology. 2000;55(12):1869–73.PubMedGoogle Scholar
  77. 77.
    Bara-Jimenez W, Catalan MJ, Hallett M, Gerloff C. Abnormal somatosensory homunculus in dystonia of the hand. Ann Neurol. 1998;44(5):828–31.PubMedGoogle Scholar
  78. 78.
    Nelson AJ, Blake DT, Chen R. Digit-specific aberrations in the primary somatosensory cortex in writer’s cramp. Ann Neurol. 2009;66(2):146–54.PubMedGoogle Scholar
  79. 79.
    Butterworth S, Francis S, Kelly E, McGlone F, Bowtell R, Sawle GV. Abnormal cortical sensory activation in dystonia: an fMRI study. Mov Disord. 2003;18(6):673–82.PubMedGoogle Scholar
  80. 80.
    Murase N, Kaji R, Shimazu H, Katayama-Hirota M, Ikeda A, Kohara N, et al. Abnormal premovement gating of somatosensory input in writer’s cramp. Brain. 2000;123(9):1813–29.PubMedGoogle Scholar
  81. 81.
    Kessler KR, Ruge D, Ilic TV, Ziemann U. Short latency afferent inhibition and facilitation in patients with writer’s cramp. Mov Disord. 2005;20(2):238–42.PubMedGoogle Scholar
  82. 82.
    Pirio Richardson S, Bliem B, Voller B, Dang N, Hallett M. Long-latency afferent inhibition during phasic finger movement in focal hand dystonia. Exp Brain Res. 2009;193(2):173–9.PubMedGoogle Scholar
  83. 83.
    Daskalakis ZJ, Paradiso GO, Christensen BK, Fitzgerald PB, Gunraj C, Chen R. Exploring the connectivity between the cerebellum and motor cortex in humans. J Physiol. 2004;557(2):689–700.PubMedCentralPubMedGoogle Scholar
  84. 84.
    Hubsch C, Roze E, Popa T, Russo M, Balachandran A, Pradeep S, et al. Defective cerebellar control of cortical plasticity in writer’s cramp. Brain. 2013;136(7):2050–62.PubMedCentralPubMedGoogle Scholar
  85. 85.
    Quartarone A, Bagnato S, Rizzo V, Siebner HR, Dattola V, Scalfari A, et al. Abnormal associative plasticity of the human motor cortex in writer’s cramp. Brain. 2003;126(12):2586–96.PubMedGoogle Scholar
  86. 86.
    Edwards MJ, Huang YZ, Mir P, Rothwell JC, Bhatia KP. Abnormalities in motor cortical plasticity differentiate manifesting and nonmanifesting DYT1 carriers. Mov Disord. 2006;21(12):2181–6.PubMedGoogle Scholar
  87. 87.
    Weise D, Schramm A, Stefan K, Wolters A, Reiners K, Naumann M, et al. The two sides of associative plasticity in writer’s cramp. Brain. 2006;129(10):2709–21.PubMedGoogle Scholar
  88. 88.
    Tamura Y, Ueki Y, Lin P, Vorbach S, Mima T, Kakigi R, et al. Disordered plasticity in the primary somatosensory cortex in focal hand dystonia. Brain. 2009;132(3):749–55.PubMedCentralPubMedGoogle Scholar
  89. 89.
    Ghilardi MF, Carbon M, Silvestri G, Dhawan V, Tagliati M, Bressman S, et al. Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann Neurol. 2003;54(1):102–9.PubMedGoogle Scholar
  90. 90.
    Priori A, Berardelli A, Mercuri B, Manfredi M. Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Brain. 1995;118(3):801–7.PubMedGoogle Scholar
  91. 91.
    Trompetto C, Curra A, Buccolieri A, Suppa A, Abbruzzese G, Berardelli A. Botulinum toxin changes intrafusal feedback in dystonia: a study with the tonic vibration reflex. Mov Disord. 2006;21(6):777–82.PubMedGoogle Scholar
  92. 92.
    Curra A, Trompetto C, Abbruzzese G, Berardelli A. Central effects of botulinum toxin type A: evidence and supposition. Mov Disord. 2004;19 Suppl 8:S60–4.PubMedGoogle Scholar
  93. 93.
    Filippi GM, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol. 1993;113(3):400–4.PubMedGoogle Scholar
  94. 94.
    Wiegand H, Erdmann G, Wellhoner HH. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedeberg’s Arch Pharmacol. 1976;292(2):161–5.Google Scholar
  95. 95.
    Pauri F, Boffa L, Cassetta E, Pasqualetti P, Rossini PM. Botulinum toxin type-A treatment in spastic paraparesis: a neurophysiological study. J Neurol Sci. 2000;181(1–2):89–97.PubMedGoogle Scholar
  96. 96.
    Byrnes ML, Thickbroom GW, Wilson SA, Sacco P, Shipman JM, Stell R, et al. The corticomotor representation of upper limb muscles in writer’s cramp and changes following botulinum toxin injection. Brain. 1998;121(5):977–88.PubMedGoogle Scholar
  97. 97.
    Gilio F, Curra A, Lorenzano C, Modugno N, Manfredi M, Berardelli A. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann Neurol. 2000;48(1):20–6.PubMedGoogle Scholar
  98. 98.
    Quartarone A, Sant’Angelo A, Battaglia F, Bagnato S, Rizzo V, Morgante F, et al. Enhanced long-term potentiation-like plasticity of the trigeminal blink reflex circuit in blepharospasm. J Neurosci. 2006;26(2):716–21.PubMedGoogle Scholar
  99. 99.
    Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med. 2005;352(5):459–67.PubMedGoogle Scholar
  100. 100.
    Coubes P, Roubertie A, Vayssiere N, Hemm S, Echenne B. Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet. 2000;355(9222):2220–1.PubMedGoogle Scholar
  101. 101.
    Volkmann J, Allert N, Voges J, Sturm V, Schnitzler A, Freund HJ. Long-term results of bilateral pallidal stimulation in Parkinson’s disease. Ann Neurol. 2004;55(6):871–5.PubMedGoogle Scholar
  102. 102.
    Cif L, Vasques X, Gonzalez V, Ravel P, Biolsi B, Collod-Beroud G, et al. Long-term follow-up of DYT1 dystonia patients treated by deep brain stimulation: an open-label study. Mov Disord. 2010;25(3):289–99.PubMedGoogle Scholar
  103. 103.
    Ostrem JL, Starr PA. Treatment of dystonia with deep brain stimulation. Neurotherapeutics. 2008;5(2):320–30.PubMedGoogle Scholar
  104. 104.
    Andrews C, Aviles-Olmos I, Hariz M, Foltynie T. Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes. J Neurol Neurosurg Psychiatry. 2010;81(12):1383–9.PubMedGoogle Scholar
  105. 105.
    Vasques X, Cif L, Gonzalez V, Nicholson C, Coubes P. Factors predicting improvement in primary generalized dystonia treated by pallidal deep brain stimulation. Mov Disord. 2009;24(6):846–53.PubMedGoogle Scholar
  106. 106.
    Ostrem JL, Racine CA, Glass GA, Grace JK, Volz MM, Heath SL, et al. Subthalamic nucleus deep brain stimulation in primary cervical dystonia. Neurology. 2011;76(10):870–8.PubMedGoogle Scholar
  107. 107.
    Tisch S, Limousin P, Rothwell JC, Asselman P, Zrinzo L, Jahanshahi M, et al. Changes in forearm reciprocal inhibition following pallidal stimulation for dystonia. Neurology. 2006;66(7):1091–3.PubMedGoogle Scholar
  108. 108.
    Tisch S, Limousin P, Rothwell JC, Asselman P, Quinn N, Jahanshahi M, et al. Changes in blink reflex excitability after globus pallidus internus stimulation for dystonia. Mov Disord. 2006;21(10):1650–5.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Neurology and Center for Movement Disorders and NeurorestorationUniversity of FloridaGainesvilleUSA
  2. 2.Department of Applied Physiology and KinesiologyUniversity of FloridaGainesvilleUSA
  3. 3.Department of Biomedical EngineeringUniversity of FloridaGainesvilleUSA

Personalised recommendations